Bariatric Medicine Alert Archives – May 1, 2007

May 1, 2007

• Insulin Resistance Following Weight Loss Surgery for Morbid Obesity

  Both LAGB and LRYGBP significantly improved insulin resistance during the first 3 months following surgery. Both operations generated similar changes in HOMA IR, although postoperative HOMA IR levels were significantly lower after LRYGBP.

  Read more

• Reduction of Biochemical Cardiac Risk Factors

  Gastric Bypass improves patient risk for Coronary Artery Disease.

  Read more

• Medicolegal Analysis of 100 Malpractice Claims

  This study found that leaks and delayed diagnosis were the most common cause of litigation.

  Read more

• Barrett's Esophagus and Intestinal Metaplasia

  Gastric bypass in patients with Barrett's esophagus and morbid obesity is an excellent antireflux operation, proved by the disappearance of symptoms and the healing of endoscopic esophagitis or peptic ulcer in all patients, which is followed by an important regression to cardiac mucosa that is length-dependent and time-dependent.

  Read more

• Duodenal-Jejunal Bypass for the Treatment of Type 2 Diabetes

  Type 2 diabetes disappeared in the absence of weight loss. This goes clearly against the theory that weight loss through calorie restriction following bypass surgery for morbid obesity is the essential mechanism.

  Read more

• Gastrogastric Fistula: It May Not be as Bad as it Sounds!!!

  Gastrogastric fistulas are an uncommon, but worrisome, complication after divided RYGB.

  Read more